Minimal tumour burden in haematological diseases: a step forward with quantitative assessment of Bence‐Jones in nephelometry?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  British Journal of Haematology

• Publication date

  2016-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bjh.13878PMID 26685003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New criteria for response assessment: role of minimal residual disease in multiple myeloma.

  2015cited by this paper
• Is This the Time to Introduce Minimal Residual Disease in Multiple Myeloma Clinical Practice?

  2015cited by this paper
• Multiple myeloma: from diagnosis to treatment.

  2013cited by this paper
• Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots

  2012cited by this paper
• Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

  2011cited by this paper
• Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

  2010cited by this paper
• UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M‐proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)

  2009cited by this paper
• International uniform response criteria for multiple myeloma

  2007cited by this paper
• International uniform response criteria for multiple myeloma

  2006cited by this paper
• Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

  2003cited by this paper

• Paradigm Shift in Monoclonal Protein Detection: From Electrophoresis-based to Mass Spectrometry–based Methods

  2025cites this paper
• Immunochemical measurement of urinary free light chains and Bence Jones proteinuria

  2025cites this paper
• The dark side of current analytic methods for Bence Jones Proteinuria.

  2022cites this paper
• κ and λ urine free light chains: a new method for quantification

  2020cites this paper
• Nanoporous silica coupled MALDI-TOF MS detection of Bence-Jones proteins in human urine for diagnosis of multiple myeloma.

  2019cites this paper
• Response to Letter to the Editor about immunochemical measurement of urine free light chains

  2018cites this paper
• Nephelometric assay of urine free light chains: an alternative and early clinical test for Bence-Jones protein quantification

  2018cites this paper
• Free light chains nephelometric assay: human urine stability in different storage conditions

  2016cites this paper